Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
FEBS Lett ; 579(9): 1973-7, 2005 Mar 28.
Article in English | MEDLINE | ID: mdl-15792805

ABSTRACT

The antifungal plant defensin DmAMP1 interacts with the fungal sphingolipid mannosyl diinositolphosphoryl ceramide (M(IP)(2)C) and induces fungal growth inhibition. We have identified SKN1, besides the M(IP)(2)C-biosynthesis gene IPT1, as a novel DmAMP1-sensitivity gene in Saccharomyces cerevisiae. SKN1 was previously shown to be a KRE6 homologue, which is involved in beta-1,6-glucan biosynthesis. We demonstrate that a Deltaskn1 mutant lacks M(IP)(2)C. Interestingly, overexpression of either IPT1 or SKN1 complemented the skn1 mutation, conferred sensitivity to DmAMP1, and resulted in M(IP)(2)C levels comparable to the wild type. These results show that SKN1, together with IPT1, is involved in sphingolipid biosynthesis in S. cerevisiae.


Subject(s)
Antifungal Agents/pharmacology , Defensins/pharmacology , Glycosphingolipids/biosynthesis , Membrane Proteins/physiology , Plant Proteins/pharmacology , Saccharomyces cerevisiae Proteins/physiology , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/metabolism , Drug Resistance, Fungal/genetics , Gene Expression Regulation, Fungal , Genes, Plant , Genetic Complementation Test , Glycosphingolipids/genetics , Membrane Proteins/genetics , Phosphotransferases (Alcohol Group Acceptor)/genetics , Phosphotransferases (Alcohol Group Acceptor)/physiology , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins/genetics , Sequence Deletion/genetics
2.
J Lipid Res ; 46(4): 759-68, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15654124

ABSTRACT

To defend themselves against fungal pathogens, plants produce numerous antifungal proteins and peptides, including defensins, some of which have been proposed to interact with fungal cell surface glycosphingolipid components. Although not known as a phytopathogen, the filamentous fungus Neurospora crassa possesses numerous genes similar to those required for plant pathogenesis identified in fungal pathogens (Galagan, J. E., et al. 2003. Nature 422: 859-868), and it has been used as a model for studying plant-phytopathogen interactions targeting fungal membrane components (Thevissen, K., et al. 2003. Peptides. 24: 1705-1712). For this study, neutral glycolipid components were extracted from wild-type and plant defensin-resistant mutant strains of N. crassa. The structures of purified components were elucidated by NMR spectroscopy and mass spectrometry. Neutral glycosphingolipids of both wild-type and mutant strains were characterized as beta-glucopyranosylceramides, but those of the mutants were found with structurally altered ceramides. Although the wild type expressed a preponderance of N-2'-hydroxy-(E)-Delta3-octadecenoate as the fatty-N-acyl component attached to the long-chain base (4E,8E)-9-methyl-4,8-sphingadienine, the mutant ceramides were found with mainly N-2'-hydroxyhexadecanoate instead. In addition, the mutant strains expressed highly increased levels of a sterol glucoside identified as ergosterol-beta-glucoside. The potential implications of these findings with respect to defensin resistance in the N. crassa mutants are discussed.


Subject(s)
Defensins/pharmacology , Drug Resistance, Fungal/genetics , Glycolipids/chemistry , Glycolipids/metabolism , Mutation/genetics , Neurospora crassa/genetics , Neurospora crassa/metabolism , Plant Proteins/pharmacology , Chromatography, Thin Layer , Defensins/metabolism , Drug Resistance, Fungal/drug effects , Glycolipids/isolation & purification , Magnetic Resonance Spectroscopy , Mass Spectrometry , Molecular Structure , Neurospora crassa/chemistry , Neurospora crassa/drug effects , Plant Proteins/metabolism
3.
J Biol Chem ; 279(6): 3900-5, 2004 Feb 06.
Article in English | MEDLINE | ID: mdl-14604982

ABSTRACT

Growth of the yeast species Candida albicans and Pichia pastoris is inhibited by RsAFP2, a plant defensin isolated from radish seed (Raphanus sativus), at micromolar concentrations. In contrast, gcs-deletion mutants of both yeast species are resistant toward RsAFP2. GCS genes encode UDP-glucose:ceramide glucosyltransferases, which catalyze the final step in the biosynthesis of the membrane lipid glucosylceramide. In an enzyme-linked immunosorbent assay-based binding assay, RsAFP2 was found to interact with glucosylceramides isolated from P. pastoris but not with soybean nor human glucosylceramides. Furthermore, the P. pastoris parental strain is sensitive toward RsAFP2-induced membrane permeabilization, whereas the corresponding gcs-deletion mutant is highly resistant to RsAFP2-mediated membrane permeabilization. A model for the mode of action of RsAFP2 is presented in which all of these findings are linked. Similarly to RsAFP2, heliomicin, a defensin-like peptide from the insect Heliothis virescens, is active on C. albicans and P. pastoris parental strains but displays no activity on the gcs-deletion mutants of both yeast species. Furthermore, heliomicin interacts with glucosylceramides isolated from P. pastoris and soybean but not with human glucosylceramides. These data indicate that structurally homologous anti-fungal peptides present in species from different eukaryotic kingdoms interact with the same target in the fungal plasma membrane, namely glucosylceramides, and as such support the hypothesis that defensins from plants and insects have evolved from a single precursor.


Subject(s)
Defensins/metabolism , Fungi/metabolism , Glucosylceramides/metabolism , Insect Proteins/metabolism , Plant Proteins/metabolism , Animals , Antifungal Agents/metabolism , Antifungal Agents/pharmacology , Antimicrobial Cationic Peptides/metabolism , Antimicrobial Cationic Peptides/pharmacology , Candida albicans/drug effects , Candida albicans/growth & development , Candida albicans/metabolism , Defensins/pharmacology , Fungi/drug effects , Fungi/growth & development , Genes, Fungal , Glucosylceramides/chemistry , Glucosylceramides/genetics , In Vitro Techniques , Insect Proteins/pharmacology , Mutation , Pichia/drug effects , Pichia/genetics , Pichia/growth & development , Pichia/metabolism , Plant Proteins/pharmacology
4.
Fungal Genet Biol ; 40(2): 176-85, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14516770

ABSTRACT

Twenty-five Neurospora crassa mutants obtained by chemical mutagenesis were screened for increased resistance to various antifungal plant defensins. Plant defensin-resistant N. crassa mutants were further tested for their cross-resistance towards other families of structurally different antimicrobial peptides. Two N. crassa mutants, termed MUT16 and MUT24, displaying resistance towards all plant defensins tested but not to structurally different antimicrobial peptides were selected for further characterization. MUT16 and MUT24 were more resistant towards plant defensin-induced membrane permeabilization as compared to the N. crassa wild-type. Based on the previously demonstrated key role of fungal sphingolipids in the mechanism of growth inhibition by plant defensins, membrane sphingolipids of MUT16 and MUT24 were analysed. Membranes of these mutants contained structurally different glucosylceramides, novel glycosylinositolphosphorylceramides, and an altered level of steryl glucosides. Evidence is provided to link these clear differences in sphingolipid profiles of N. crassa mutants with their resistance towards different plant defensins.


Subject(s)
Defensins/pharmacology , Drug Resistance, Fungal/genetics , Neurospora crassa/drug effects , Neurospora crassa/genetics , Plant Proteins/pharmacology , Anti-Infective Agents/pharmacology , Cell Membrane/chemistry , Cell Membrane Permeability/drug effects , Cell Membrane Permeability/genetics , Ethyl Methanesulfonate/pharmacology , Fluorescent Dyes/metabolism , Mutagens/pharmacology , Mutation , Neurospora crassa/growth & development , Neurospora crassa/metabolism , Organic Chemicals , Sphingolipids/analysis
5.
FEMS Microbiol Lett ; 226(1): 169-73, 2003 Sep 12.
Article in English | MEDLINE | ID: mdl-13129623

ABSTRACT

DmAMP1, an antifungal plant defensin from Dahlia merckii, was shown previously to require the presence of sphingolipids for fungicidal action against Saccharomyces cerevisiae. Sphingolipids may stabilize glycosylphosphatidylinositol (GPI)-anchored proteins, which interact with DmAMP1, or they may directly serve as DmAMP1 binding sites. In the present study, we demonstrate that S. cerevisiae disruptants in GPI-anchored proteins showed small or no increased resistance towards DmAMP1 indicating no involvement of these proteins in DmAMP1 action. Further, studies using an enzyme-linked immunosorbent assay (ELISA)-based binding assay revealed that DmAMP1 interacts directly with sphingolipids isolated from S. cerevisiae and that this interaction is enhanced in the presence of equimolar concentrations of ergosterol. Therefore, DmAMP1 antifungal action involving membrane interaction with sphingolipids and ergosterol is proposed.


Subject(s)
Antimicrobial Cationic Peptides/metabolism , Antimicrobial Cationic Peptides/pharmacology , Defensins , Plant Proteins/metabolism , Plant Proteins/pharmacology , Saccharomyces cerevisiae/drug effects , Sphingolipids/metabolism , Enzyme-Linked Immunosorbent Assay , Ergosterol/metabolism , Gene Deletion , Glycosylphosphatidylinositols/metabolism , Membrane Glycoproteins/genetics , Microbial Sensitivity Tests , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae Proteins/metabolism
6.
Peptides ; 24(11): 1705-12, 2003 Nov.
Article in English | MEDLINE | ID: mdl-15019201

ABSTRACT

Plant defensins are small, basic, cysteine-rich peptides that are generally active against a broad spectrum of fungal and yeast species at micromolar concentrations. Some of these defensins interact with fungal-specific lipid components in the plasmamembrane. Structural differences of these membrane components between fungal and plant cells probably account for the selective activity of plant defensins against fungal pathogens and their nonphytotoxic properties. This review will focus on different classes of complex lipids in fungal membranes and on the selective interaction of plant defensins with these complex lipids.


Subject(s)
Antifungal Agents/metabolism , Antifungal Agents/pharmacology , Cell Membrane/drug effects , Defensins/metabolism , Defensins/pharmacology , Fungi/cytology , Fungi/drug effects , Plant Proteins/metabolism , Plant Proteins/pharmacology , Cell Membrane/chemistry , Cell Membrane/metabolism , Fungi/metabolism , Models, Biological
SELECTION OF CITATIONS
SEARCH DETAIL
...